Caption Management’s Novartis NVS Stock Holding History

Caption Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,500	Closed	-$798K	–	1503
2024 Q2	$798K	Buy	+7,500	New	+$753K	0.01%	714
2023 Q3	–	Sell	-81,700	Closed	-$8.24M	–	1447
2023 Q2	$8.24M	Buy	+81,700	New	+$8.17M	0.15%	173
2023 Q1	–	Sell	-21,000	Closed	-$1.91M	–	1402
2022 Q4	$1.91M	Buy	+21,000	New	+$1.77M	0.03%	572
2022 Q1	–	Sell	-95,000	Closed	-$8.31M	–	1785
2021 Q4	$8.31M	Buy	95,000 +53,003	+126%	+$4.4M	0.09%	299
2021 Q3	$3.44M	Buy	+41,997	New	+$3.78M	0.04%	581
2021 Q2	–	Sell	-20,000	Closed	-$1.78M	–	1496
2021 Q1	$1.71M	Buy	+20,000	New	+$1.79M	0.04%	557
2020 Q2	–	Sell	-5,000	Closed	-$412K	–	1122
2020 Q1	$412K	Buy	+5,000	New	+$446K	0.02%	582

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Caption Management's NVS Position: Q3 2024 in Review

Caption Management sold out of Novartis (NVS) in Q3 2024, closing a stake of 7,500 shares — an estimated $798K sold.

Caption Management first reported a position in NVS in Q1 2020 and held it in 7 quarters. The position peaked at $8.31M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

Caption Management reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
Caption Management sold 7,500 Novartis shares in Q3 2024, an estimated $798K.
Caption Management first reported a position in Novartis in Q1 2020 and held it in 7 quarters.
Caption Management's Novartis position peaked at $8.31M in Q4 2021.
1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.